Fetus and newborn affected by maternal complications of pregnancy

P16_FET_NEWB_MATERN_COMPLICATIO_PREGNAC

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P01 Cause of death: ICD-10 — P01 2 out of 7 registries used, show all original rules.	230
4. Check minimum number of events None	230
5. Include endpoints None	230
6. Filter based on genotype QC (FinnGen only)	206

Control definitions (FinnGen only)

Control exclude: P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P0[0-4]
Name in latin: Fetus et neonatus complicationibus graviditatis maternis affectus

NAME	P16_FET_NEWB_MATERN_COMPLICATIO_PREGNAC
CONTROL_EXCLUDE	P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P01
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P01
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Fetus and newborn affected by maternal complications of pregnancy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19742	9127	10615
Only index persons	7988	3741	4247
Unadjusted period prevalence (%)
Whole population	0.28	0.26	0.30
Only index persons	0.15	0.14	0.16
Median age at first event (years)
Whole population	-	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	206	120	86
Unadjusted period prevalence (%)	0.04	0.04	0.04
Median age at first event (years)	0.00	0.00	0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
230: Matched controls
2299

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P07.3

ICD-10 Finland

Other preterm infants

43.7

177.0

124

P01.5

ICD-10 Finland

Fetus and newborn affected by multiple pregnancy

+∞

119.5

104

P01.10

ICD-10 Finland

Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery

+∞

105.5

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

15.3

76.2

P59.0

ICD-10 Finland

Neonatal jaundice associated with preterm delivery

15.6

39.1

P07.12

ICD-10 Finland

Other low birth weight 2000-2499 g

15.9

36.4

WX722

NOMESCO Finland

PEEP

8.8

27.1

P22.1

ICD-10 Finland

Transient tachypnoea of newborn

8.9

22.7

P07.11

ICD-10 Finland

Other low birth weight 1500-1999 g

36.4

20.7

P39.9

ICD-10 Finland

Infection specific to the perinatal period, unspecified

21.1

15.9

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

4.0

12.8

114

P22.0

ICD-10 Finland

Respiratory distress syndrome of newborn

19.4

12.3

P07.1

ICD-10 Finland

Other low birth weight

+∞

11.5

P07.2

ICD-10 Finland

Extreme immaturity

26.6

11.3

P01.11

ICD-10 Finland

Fetus and newborn affected by premature rupture of membranes more than 7 days before delivery

+∞

10.5

A11JC

ATC

Vitamins, other combinations

15.5

10.2

WW805

NOMESCO Finland

Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse

42.0

10.1

P05.1

ICD-10 Finland

Small for gestational age

10.7

9.7

602

Kela drug reimbursment

Children's severe malnutrition

4.0

9.0

P07.10

ICD-10 Finland

Other low birth weight 1000-1499 g

25.2

9.0

P27.1

ICD-10 Finland

Bronchopulmonary dysplasia originating in the perinatal period

19.1

7.7

WX882

NOMESCO Finland

High dependency care

2.6

7.5

209

R4110

NOMESCO Finland

Physiotherapy

2.3

7.4

417

P70.4

ICD-10 Finland

Other neonatal hypoglycaemia

4.4

7.4

P00.0

ICD-10 Finland

Fetus and newborn affected by maternal hypertensive disorders

+∞

7.3

P03.4

ICD-10 Finland

Fetus and newborn affected by caesarean delivery

+∞

7.3

P07.02

ICD-10 Finland

Extremely low birth weight 750-999 g

41.3

6.8

P70.0

ICD-10 Finland

Syndrome of infant of mother with gestational diabetes

6.5

6.6

P01.8

ICD-10 Finland

Fetus and newborn affected by other maternal complications of pregnancy

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002582) Erythrocytes [#/volume] in Urine

605

1.58

2.71

4.8

5.4

17.33

25.63

e6/l

0.49

458

(3030467) Casts [#/volume] in Urine by Automated count

570

1.56

2.49

4.2

5.1

0.30

0.27

e6/l

0.05

428

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

100

2.09

2.28

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

100

2.09

2.28

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

631

1.49

2.16

5.7

5.6

—

(3000850) Epithelial cells [#/volume] in Urine

393

1.56

2.10

4.0

4.1

7.54

7.47

e6/l

0.01

349

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

4.23

1.83

1.0

147.40

163.42

g/l

—

(3022670) pH of Venous cord blood

2.82

1.81

1.0

—

(3045414) Leukocytes [Presence] in Urine

2.41

1.80

1.5

1.7

—

(36304419) Bacteria [Presence] in Urine

579

1.44

1.75

4.2

5.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

557

1.43

1.65

12.2

12.5

1.40

0.95

mmol/l

0.74

390

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

2.17

1.58

1.0

162.50

166.46

g/l

0.39

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

1.54

0.0

2.3

—

13.76

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

1.53

0.0

2.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

385

1.45

1.50

3.7

4.6

1.71

2.10

e6/l

0.19

227

(3026782) Osmolality of Urine

387

1.44

1.46

2.9

3.8

540.61

577.07

mosm/kgh2o

0.38

336

(3018095) Leukocytes [#/volume] in Urine

711

1.36

1.42

6.1

6.2

74.34

47.60

e6/l

0.22

473

(3024891) Influenza virus A+B Ag [Presence] in Specimen

135

1.70

1.41

1.4

1.5

—

(3020891) Body temperature

0.00

1.34

0.0

8.2

—

(3014051) Protein [Presence] in Urine by Test strip

2.40

1.30

1.5

2.0

—

(3002256) Pathology report gross observation

116

0.42

1.29

2.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

141

0.48

1.25

1.6

1.4

—

(3000330) Specific gravity of Urine by Test strip

2.09

1.24

1.8

1.9

—

(3022217) INR in Platelet poor plasma by Coagulation assay

409

0.67

1.23

2.6

6.1

1.03

1.12

inr

1.56

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

375

0.65

1.23

2.2

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

837

0.75

1.20

3.2

3.0

1.48

1.43

mmol/l

0.56

788

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

383

1.39

1.20

3.8

4.4

0.31

0.86

e6/l

2.23

224

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2.34

1.19

3.0

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.98

1.19

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.09

1.16

1.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

254

0.60

1.15

2.9

5.2

9.05

8.21

g/l

0.43

248

(42529406) Shigella sp [Presence] in Stool by Culture

1.94

1.14

1.0

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

193

0.55

1.14

10.0

14.8

105.45

105.85

mmol/l

0.15

193

(3043238) Trisomy 21 risk [Likelihood] in Fetus

2.03

1.13

1.8

1.4

—

(40758558) Short blood count panel - Blood

697

1.30

1.08

7.8

11.5

—

(3022313) Gas panel - Capillary blood

502

1.32

1.05

13.1

12.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

2.30

1.04

1.6

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

493

0.73

1.02

3.5

2.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

186

0.57

1.01

1.5

1.2

14.50

18.53

iu/ml

—

(3037121) Protein [Mass/volume] in Urine

124

1.58

1.00

8.4

9.0

0.31

0.36

g/l

0.10

110

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

2.20

0.98

1.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.20

0.98

1.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.78

0.98

1.2

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

133

1.55

0.98

1.7

1.9

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.98

0.0

2.5

—

1.05

—

(3023368) Bacteria identified in Blood by Culture

315

1.37

0.97

3.3

5.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

119

0.49

0.96

1.0

1.4

—

(3017732) Neutrophils [#/volume] in Blood

120

0.49

0.96

4.5

1.7

3.47

4.96

e9/l

—

114

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.92

0.95

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2.10

0.90

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.82

0.89

1.0

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

138

0.56

0.86

5.0

2.3

—

76.21

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

165

0.59

0.85

2.2

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

212

0.64

0.85

2.6

2.4

0.87

0.95

g/l

0.27

207

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.73

0.84

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.90

0.82

3.0

1.6

—

(40768443) Skin Pathology biopsy report

1.90

0.82

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.79

0.0

6.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.6

—

19.70

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

100

0.49

0.79

11.2

21.2

0.50

0.63

—

100

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.79

0.0

3.2

—

1.70

—

(3049233) Organic acids panel - Urine

0.00

0.78

0.0

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

407

0.75

0.76

6.8

5.1

7.25

8.20

mmol/l

0.46

383

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

135

0.58

0.76

5.4

2.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

2.11

0.75

8.2

6.8

30.96

24.17

ug/l

—

(3016879) Cocaine [Presence] in Urine

194

0.65

0.75

2.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.87

0.74

1.6

1.3

—

(3005033) Fetal Nuchal fold Thickness US

1.87

0.74

1.6

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.02

0.73

1.0

—

(3036180) Methadone [Presence] in Urine

1.87

0.69

1.4

1.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.52

0.68

1.3

2.6

5.25

5.14

pmol/l

0.19

(3027008) Opiates [Presence] in Urine

211

0.69

0.66

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

211

0.69

0.66

1.9

2.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

106

1160

0.84

0.63

5.0

4.4

5.22

7.89

mm/h

7.25

1073

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

471

0.79

0.63

3.2

2.5

—

(3027944) Amphetamines [Presence] in Urine

209

0.70

0.63

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.68

0.61

7.8

12.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.59

0.61

1.6

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.59

0.61

1.6

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.59

0.61

1.6

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.59

0.61

1.6

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

230

0.72

0.61

4.2

15.4

93.24

89.99

0.18

230

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.60

0.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

114

1.43

0.60

1.7

1.6

430.63

365.02

mu/l

0.35

107

(3004716) Salmonella sp identified in Stool by Organism specific culture

176

1.34

0.59

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.58

0.0

6.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

0.57

20.2

19.8

97.40

95.23

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

0.56

0.57

20.2

19.4

1.14

1.04

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

151

1.35

0.56

1.4

280.50

176.39

iu/ml

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.55

0.55

1.9

1.4

—

(3011288) Drugs identified in Urine by Screen method

158

0.68

0.55

2.5

2.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

291

0.77

0.54

3.0

2.9

295.74

348.99

nmol/l

0.83

278

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

108

992

1.17

0.53

2.0

2.1

—

(3016038) Potassium [Moles/volume] in Urine

1.51

0.52

2.8

26.50

34.53

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

627

0.84

0.51

3.6

4.4

—

(3022621) pH of Urine by Test strip

1.51

0.50

1.6

2.0

—

(3028300) Cannabinoids [Presence] in Urine

211

0.74

0.50

1.9

2.0

—

(3013115) Eosinophils [#/volume] in Blood

128

1197

1.16

0.48

9.9

12.5

0.18

0.22

e9/l

1.88

107

991

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

154

1615

0.86

0.47

8.2

10.1

22.67

24.70

u/l

0.88

147

1549

(3017143) Hepatitis C virus Ab [Presence] in Serum

273

0.78

0.45

1.9

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

148

1.31

0.45

1.4

1.5

—

(3012516) Albumin [Mass/volume] in Urine

140

0.70

0.45

3.9

47.19

245.19

mg/l

—

109

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.38

0.44

1.4

1.3

12.05

5.20

u/ml

—

(3000494) Fungus identified in Specimen by Culture

162

0.73

0.44

1.4

1.8

—

(3026008) Bacteria identified in Urine by Culture

447

1.18

0.44

2.3

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

293

0.80

0.44

2.7

2.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.63

0.43

1.8

1.2

—

(3010813) Leukocytes [#/volume] in Blood

204

2086

0.80

0.43

17.7

19.1

7.09

7.08

e9/l

0.01

197

1970

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

641

1.16

0.42

1.7

1.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

1.37

0.42

11.2

7.8

0.00

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.39

0.42

5.9

6.3

2.76

2.58

ug/l

—

(3032641) Amino acids panel - Urine

0.00

0.41

0.0

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

418

0.84

0.41

1.9

3.2

42.26

76.42

ug/g

1.55

334

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.41

0.0

2.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.41

0.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

0.00

0.41

0.0

1.5

—

34.57

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

2.6

—

8.56

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.41

0.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

1.48

0.40

1.0

—

(3026361) Erythrocytes [#/volume] in Blood

204

2084

0.81

0.40

17.6

19.1

4.63

4.57

e12/l

1.07

197

1967

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.40

0.0

2.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

136

0.72

0.39

4.2

2.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.32

0.37

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

204

2082

0.82

0.37

17.6

20.6

39.48

38.77

1.66

197

1997

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.36

0.37

1.4

1.2

—

(3003694) ABO and Rh group [Type] in Blood

600

0.87

0.36

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

1.28

0.36

1.4

2.3

—

(40761535) Cells panel - Urine sediment

0.65

0.36

15.8

3.9

—

(3052851) Hemolysis interference index of Serum or Plasma

0.64

0.36

2.2

3.4

—

(3022145) Colonoscopy Study observation

0.64

0.36

1.8

1.5

—

(3007461) Platelets [#/volume] in Blood

204

2081

0.82

0.36

17.7

19.2

284.78

275.11

e9/l

1.11

197

1974

(3035350) Ketones [Presence] in Urine by Test strip

739

1.13

0.34

3.7

3.9

0.00

estimate

—

122

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.34

0.34

2.3

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

0.67

0.33

17.2

19.2

0.57

0.74

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.66

0.33

1.8

1.3

—

(40768797) Stomach Pathology biopsy report

132

0.75

0.33

1.3

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.28

0.32

5.3

5.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

218

0.81

0.32

2.6

5.6

39.10

1191.31

ng/l

—

134

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

131

0.75

0.32

1.8

1.4

—

(3021901) Oxygen saturation in Capillary blood

1.36

0.31

8.7

11.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

113

1069

1.11

0.31

6.0

4.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

461

1.14

0.30

2.8

3.6

—

(1761868) Lipid panel - Serum or Plasma

238

0.82

0.30

2.2

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

180

1847

0.88

0.30

11.9

12.9

21.08

24.21

mg/l

0.60

130

1254

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.23

0.29

20.4

4.4

43.83

6.15

u/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

736

1.11

0.29

5.3

5.7

0.00

estimate

—

124

(3017181) Myelocytes/100 leukocytes in Blood

103

1.28

0.28

11.2

7.6

0.50

0.40

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.29

0.28

11.2

6.1

1.83

0.30

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.29

0.28

1.3

1.1

—

(3006315) Basophils [#/volume] in Blood

122

1163

1.10

0.28

9.7

11.3

0.04

e9/l

0.39

100

940

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

100

944

1.10

0.28

14.8

16.1

1.24

1.23

mmol/l

0.94

884

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

116

0.77

0.28

1.2

1.8

2.44

2.41

mmol/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

823

0.90

0.28

8.4

6.3

116.56

113.83

ml/min/173m2

0.37

494

(3035933) Granulocytes/100 leukocytes in Blood

1.26

0.28

1.1

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

738

1.11

0.27

3.7

3.9

0.00

estimate

—

122

(3001604) Monocytes [#/volume] in Blood

122

1165

1.10

0.27

9.7

11.2

0.60

0.58

e9/l

0.49

100

943

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.22

0.27

2.0

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.31

0.26

1.1

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.66

0.26

1.6

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

129

1237

1.10

0.26

10.7

13.6

3.28

3.40

e9/l

0.24

105

1007

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.19

0.25

1.6

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.19

0.25

2.8

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

222

0.84

0.24

3.1

7.0

49.33

65.73

e9/l

1.27

142

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

920

1.09

0.24

14.4

17.8

1.25

1.24

mmol/l

1.44

879

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

939

0.91

0.24

2.4

2.2

5.28

5.32

mmol/l

0.11

846

(3000991) Gas panel - Venous blood

481

0.89

0.24

10.1

13.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

210

0.84

0.23

2.4

2.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.29

0.23

5.2

3.3

2.87

2.92

e9/l

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.29

0.23

5.4

3.5

43.00

47.69

—

(4200892) Spirometry reversibility

1.26

0.23

1.2

1.5

—

(4035726) Immunohistochemistry procedure

0.74

0.23

2.6

2.2

—

(3013512) EKG study

172

1.18

0.23

2.1

2.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.74

0.23

1.0

2.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1.28

0.22

1.3

1.5

870.09

976.65

nmol/l

—

(3002032) Base excess in Venous blood by calculation

520

0.90

0.22

8.8

13.4

0.69

0.88

mmol/l

0.12

398

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

885

0.92

0.22

1.7

1.9

1.91

3.55

u/ml

0.72

139

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.19

0.21

1.6

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.19

0.21

1.0

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

423

1.11

0.21

3.0

4.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

404.36

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.21

0.0

3.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.21

0.0

1.0

—

108.64

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.21

0.0

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

166

0.83

0.21

2.7

2.2

427.33

172.49

u/ml

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

539

0.91

0.21

7.5

11.1

37.20

37.35

g/l

0.05

517

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

187

0.84

0.21

1.9

2.5

8.49

69.87

ng/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.17

0.21

2.0

2.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.21

0.0

2.2

—

3.89

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

40207.69

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

1.50

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.20

0.0

3.1

—

21.21

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.0

—

311.86

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.20

0.0

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

207

0.86

0.20

2.4

2.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.22

0.20

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.18

0.19

1.2

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

194

1.15

0.19

1.1

1.3

5.81

6.68

u/ml

0.07

150

(3008401) Mugwort IgE Ab [Units/volume] in Serum

194

1.15

0.19

1.1

1.3

0.42

0.79

u/ml

0.45

144

(3026493) Urate [Moles/volume] in Serum or Plasma

195

0.86

0.18

9.8

7.1

323.53

268.03

umol/l

1.36

182

(3000492) Spirometry study

100

1.21

0.18

1.7

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

859

0.93

0.18

1.8

1.51

1.42

g/l

0.26

442

(3042936) Bacteria identified in Isolate by Culture

195

1.14

0.18

2.1

—

(36660697) Celiac disease serology panel - Serum

391

0.91

0.18

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.11

0.17

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.72

0.17

2.6

2.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.77

0.16

4.0

5.5

104.17

93.91

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

265

0.89

0.16

3.1

4.4

316.83

346.48

u/l

0.06

259

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1.16

0.15

1.8

2.1

—

(3015736) pH of Urine

647

1.07

0.15

3.6

3.7

6.23

6.34

0.18

(40768804) Tissue Pathology biopsy report

326

0.91

0.15

1.9

1.7

—

(3019150) Specific gravity of Urine by Refractometry

377

0.92

0.15

3.7

3.4

1.02

kg/l

0.31

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

0.79

0.15

2.6

2.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

0.79

0.15

2.6

2.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

118

0.84

0.14

2.2

1.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

100

0.79

0.14

2.4

2.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

314

0.91

0.14

2.5

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

355

1.08

0.13

4.0

3.9

0.00

estimate

—

121

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

168

0.88

0.12

2.5

2.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

113

1100

1.05

0.12

10.7

12.1

—

(3025159) Blasts/100 leukocytes in Blood

1.17

0.12

12.8

7.8

0.00

0.06

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

211

1.10

0.11

1.1

1.3

2.58

3.24

u/ml

0.10

159

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

149

1462

1.05

0.11

3.9

3.7

2.13

2.07

mu/l

0.20

137

1368

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.14

0.10

1.6

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

106

1.14

0.10

2.6

3.2

18.09

23.16

mu/l

0.22

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.06

0.09

1.8

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

116

1.13

0.09

1.3

2.2

8.84

7.09

nmol/l

0.25

100

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

491

0.95

0.09

3.4

3.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

302

1.07

0.09

3.1

8.0

1.32

2.72

mg/l

0.96

225

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

287

0.93

0.08

1.0

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

323

1.06

0.08

1.8

1.6

108.89

97.26

pmol/l

0.94

165

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.85

0.08

1.5

1.4

5.45

29.13

u/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.07

0.07

2.3

2.2

—

(3044889) 12 lead EKG panel

639

0.96

0.07

2.3

2.2

—

(3044640) Blood type and Crossmatch panel - Blood

472

1.05

0.07

3.3

5.0

—

(3025941) Bacteria identified in Stool by Culture

1.03

0.07

1.0

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.86

0.07

3.3

2.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.88

0.07

1.3

3.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.86

0.07

2.4

2.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.86

0.07

2.4

2.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

100

0.90

0.06

2.2

2.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

284

0.94

0.06

2.1

2.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

119

1.10

0.06

1.6

1.7

—

(3019198) Lymphocytes [#/volume] in Blood

121

1193

1.03

0.05

9.8

11.2

2.78

2.54

e9/l

0.81

102

1003

(3041096) Erythrocytes [Presence] in Urine by Automated

333

0.95

0.05

4.3

3.4

—

(3021589) Normoblasts [#/volume] in Blood

111

1124

0.98

0.04

11.3

13.2

0.00

0.01

e9/l

0.51

834

(3048929) Epstein Barr virus Ab [Presence] in Serum

291

0.96

0.04

2.3

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

502

0.97

0.04

2.9

2.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

512

0.97

0.04

2.3

3.4

2.54

2.73

mg/l

0.30

461

(3020779) Urea [Moles/volume] in Serum or Plasma

330

0.96

0.03

17.6

16.4

4.85

4.98

mmol/l

0.12

322

(40761511) CBC panel - Blood by Automated count

180

1810

0.97

0.03

9.5

9.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

118

0.93

0.03

1.5

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1.08

0.02

14.2

14.0

22.34

23.12

mmol/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

117

0.94

0.02

2.3

2.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

496

0.98

0.00

7.0

12.7

23.16

23.36

mmol/l

0.20

496

(3009214) Lutropin [Units/volume] in Serum or Plasma

164

1.04

0.00

2.2

2.4

5.73

5.34

u/l

0.13

105

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

132

1325

0.99

0.00

3.4

3.3

14.63

14.39

pmol/l

0.40

116

1207

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

163

0.98

0.00

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

140

1.00

0.00

1.9

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

338

1.01

0.00

2.6

2.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

195

1945

1.01

0.00

4.1

3.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

755

1.01

0.00

4.3

3.3

34.25

36.71

mmol/mol

1.49

712

(40761536) Microorganisms panel - Urine sediment

115

1.05

0.00

3.1

3.6

—

(3028707) Methadone [Presence] in Urine by Screen method

102

0.98

0.00

2.3

—

(3006598) pH of Arterial cord blood

145

1.04

0.00

1.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

245

0.98

0.00

2.5

2.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

146

1.03

0.00

1.5

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

6.6

—

4.46

—

(3016228) CD19 cells/100 cells in Blood

0.00

-0.00

0.0

4.5

—

14.67

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

103.00

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

1.88

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.2

—

4.92

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3025130) Human papilloma virus identified in Specimen

0.00

-0.00

0.0

2.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.97

-0.00

1.8

1.4

1.13

1.17

g/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(3012441) Differential panel - Pleural fluid

0.00

-0.00

0.0

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

-0.00

0.0

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.2

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.98

-0.00

1.4

1.2

58.80

78.61

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.00

-0.00

0.0

1.3

—

6.92

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.91

-0.00

2.3

2.0

5.92

3.95

u/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

0.90

-0.00

2.0

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

2.3

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

1.01

-0.00

2.1

6.3

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.1

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

4.7

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

-0.00

0.0

1.5

—

13.21

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.00

-0.00

0.0

5.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.69

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.99

-0.00

1.9

2.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.99

-0.00

1.0

1.1

—

9.08

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

14.2

—

39.40

—

(3019225) pH of Specimen

0.92

-0.00

13.2

4.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.93

-0.00

2.3

6.0

261.75

392.14

mg/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

866.43

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.86

-0.00

2.4

4.8

24.80

25.22

umol/l

—

(40763791) Oxygen content in Venous blood by calculation

0.00

-0.00

0.0

2.2

—

16.48

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.00

-0.00

1.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

0.00

-0.00

0.0

3.0

—

0.90

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

8.00

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.00

-0.00

0.0

1.2

—

1.01

—

(40768793) Breast Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

1.7

—

14.83

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.89

-0.00

1.5

5.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

2.0

—

4.01

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

-0.00

0.0

20.8

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

4.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_FET_NEWB_MATERN_COMPLICATIO_PREGNAC and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_FET_NEWB_MATERN_COMPLICATIO_PREGNAC.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_FET_NEWB_MATERN_COMPLICATIO_PREGNAC – Fetus and newborn affected by maternal complications of pregnancy

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Fetus and newborn affected by maternal complications of pregnancy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints